
Results
194
Companies which are potentially undervalued and in an acceptable financial position.
194 companies
Qiagen
Market Cap: US$7.6b
Provides sample to insight solutions that transform biological samples into molecular insights worldwide.
QGEN
US$36.28
7D
-2.0%
1Y
-26.2%
Trulieve Cannabis
Market Cap: US$1.9b
Operates as a cannabis retailer in the United States.
TRLV
US$9.12
7D
-7.5%
1Y
178.9%
Verastem
Market Cap: US$362.0m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$4.25
7D
6.3%
1Y
-8.0%
High Tide
Market Cap: CA$291.7m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.24
7D
1.9%
1Y
8.0%
Tasly Pharmaceutical Group
Market Cap: CN¥20.5b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥13.87
7D
-2.4%
1Y
-11.2%
Otsuka Holdings
Market Cap: JP¥5.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,715.00
7D
3.4%
1Y
51.4%
Pharma Mar
Market Cap: €1.2b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€69.15
7D
1.2%
1Y
-15.0%
Cipher Pharmaceuticals
Market Cap: CA$414.7m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$16.33
7D
0.8%
1Y
26.6%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.66
7D
4.2%
1Y
85.1%
Kissei Pharmaceutical
Market Cap: JP¥163.3b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,005.00
7D
0.6%
1Y
-2.2%
CorMedix
Market Cap: US$680.2m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.67
7D
0.9%
1Y
-47.6%
Regeneron Pharmaceuticals
Market Cap: US$62.1b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$612.50
7D
-0.4%
1Y
19.6%
Hypera
Market Cap: R$14.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.24
7D
-1.3%
1Y
-27.7%
Sanofi
Market Cap: €87.0b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€73.47
7D
-2.9%
1Y
-12.2%
Supernus Pharmaceuticals
Market Cap: US$2.6b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$44.38
7D
1.2%
1Y
38.7%
Dong-A Socio Holdings
Market Cap: ₩523.0b
Engages in the pharmaceutical business in South Korea.
A000640
₩77,500.00
7D
-9.8%
1Y
-31.0%
Elanco Animal Health
Market Cap: US$12.1b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.90
7D
-1.6%
1Y
79.0%
Bayer
Market Cap: €37.5b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€37.74
7D
4.8%
1Y
42.5%
Vetoquinol
Market Cap: €822.8m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€72.40
7D
5.1%
1Y
1.1%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩242,000.00
7D
1.0%
1Y
-34.2%
Yunnan Baiyao GroupLtd
Market Cap: CN¥86.8b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥48.53
7D
-1.8%
1Y
-12.4%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥53.5b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥22.26
7D
1.9%
1Y
-10.6%
Bavarian Nordic
Market Cap: DKK 13.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 175.50
7D
-4.7%
1Y
0.8%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,833.50
7D
0.9%
1Y
11.3%
Ardelyx
Market Cap: US$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.05
7D
6.4%
1Y
66.7%
Collegium Pharmaceutical
Market Cap: US$1.1b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$33.45
7D
-2.2%
1Y
11.9%
Prestige Consumer Healthcare
Market Cap: US$2.2b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$45.46
7D
-2.6%
1Y
-46.1%
Dong-E-E-Jiao
Market Cap: CN¥29.1b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥45.30
7D
-5.6%
1Y
-13.9%
Virbac
Market Cap: €2.8b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€335.50
7D
-0.4%
1Y
3.2%
Diaceutics
Market Cap: UK£125.7m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.45
7D
1.4%
1Y
27.3%
Dong-A ST
Market Cap: ₩333.1b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩33,650.00
7D
-7.9%
1Y
-26.4%
Decibel Cannabis
Market Cap: CA$69.2m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
0%
1Y
71.4%
Tarsus Pharmaceuticals
Market Cap: US$2.7b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$63.56
7D
2.8%
1Y
56.6%
Fennec Pharmaceuticals
Market Cap: US$314.7m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$9.53
7D
3.7%
1Y
18.1%
Journey Medical
Market Cap: US$171.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.43
7D
1.4%
1Y
0.8%
Genscript Biotech
Market Cap: HK$24.2b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.87
7D
-5.3%
1Y
-28.8%